Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Sales (2021 - 2026)

HeartSciences' Return on Sales history spans 6 years, with the latest figure at 980.79% for Q1 2026.

  • For Q1 2026, Return on Sales fell 104254.0% year-over-year to 980.79%; the TTM value through Jan 2026 reached 980.79%, down 104254.0%, while the annual FY2025 figure was 2035.18%, 167712.0% down from the prior year.
  • Return on Sales reached 980.79% in Q1 2026 per HSCS's latest filing, down from 972.69% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 377.11% in Q2 2024 to a low of 1227.83% in Q2 2023.
  • Average Return on Sales over 5 years is 440.73%, with a median of 483.05% recorded in 2025.
  • Peak YoY movement for Return on Sales: surged 160495bps in 2024, then plummeted -117620bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 661.67% in 2022, then surged by 32bps to 448.3% in 2023, then skyrocketed by 104bps to 17.88% in 2024, then tumbled by -5540bps to 972.69% in 2025, then dropped by -1bps to 980.79% in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Return on Sales are 980.79% (Q1 2026), 972.69% (Q4 2025), and 1083.06% (Q3 2025).